StreetInsider.com After Hours Movers:

Introgen Therapeutics (NASDAQ: INGN) 10.5% HIGHER; A cancer-suppressing gene has been successfully delivered into the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE